Skip to main content
Quest Diagnostics

Heparin-Induced Thrombocytopenia Testing: ELISA Based Anti-Platelet Factor 4 Polyspecific and IgG-Specific Antibody Detection Assays Compared to the Unfractionated Heparin Serotonin Release Assay

ASH 2021

American Society of Hemaltology

Orlando, FL, December 11-14, 2021

Heparin-Induced Thrombocytopenia Testing: ELISA Based Anti-Platelet Factor 4 Polyspecific and IgG-Specific Antibody Detection Assays Compared to the Unfractionated Heparin Serotonin Release Assay

Authors: Wong EC, Worfolk LA, Bi C, Noh LJ,  Espinoza A, Wu W, Sahud MA, Racke FK, Dlott JS

Specialties: Hematology, Hemostatis, Thrombosis, Oncology

Related content

Test FAQ
Anti PF4 and Serotonin Release Assay SRA for Diagnosing Heparin induced Thrombocytopenia Thrombosis HIT HITT
Conference Presentation
Concordance of Low Molecular Weight and Unfractionated Heparin Serotonin Release Assays
Publication
Therapeutic plasma exchange and intravenous immune globulin in the treatment of heparin induced thrombocytopenia A systematic review
Test FAQ
Prothrombin Time With INR
Test FAQ
Phosphatidylserine-Prothrombin Antibodies, IgG, IgM

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.